Mean platelet volume: A link between thrombosis and inflammation? AY Gasparyan, L Ayvazyan, DP Mikhailidis, GD Kitas Current pharmaceutical design 17 (1), 47-58, 2011 | 1696 | 2011 |
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors AY Gasparyan, L Ayvazyan, H Blackmore, GD Kitas Rheumatology international 31 (11), 1409-1417, 2011 | 642 | 2011 |
The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases AY Gasparyan, L Ayvazyan, U Mukanova, M Yessirkepov, GD Kitas Annals of laboratory medicine 39 (4), 345-357, 2019 | 482 | 2019 |
The role of aspirin in cardiovascular prevention: implications of aspirin resistance AY Gasparyan, T Watson, GYH Lip Journal of the American College of Cardiology 51 (19), 1829-1843, 2008 | 388 | 2008 |
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets DP Misra, V Agarwal, AY Gasparyan, O Zimba Clinical rheumatology 39 (7), 2055-2062, 2020 | 339 | 2020 |
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad S Ahmed, O Zimba, AY Gasparyan Clinical Rheumatology 39, 2529-2543, 2020 | 288 | 2020 |
Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy AY Gasparyan, A Sandoo, A Stavropoulos-Kalinoglou, GD Kitas Rheumatology international 30 (8), 1125-1129, 2010 | 267 | 2010 |
Diversity, value and limitations of the journal impact factor and alternative metrics L Bornmann, W Marx, AY Gasparyan, GD Kitas Rheumatology International 32 (7), 1861-1867, 2012 | 208 | 2012 |
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications AY Gasparyan, A Stavropoulos-Kalinoglou, DP Mikhailidis, KMJ Douglas, ... Rheumatology international 31 (2), 153-164, 2011 | 203 | 2011 |
Information and misinformation on COVID-19: a cross-sectional survey study L Gupta, AY Gasparyan, DP Misra, V Agarwal, O Zimba, M Yessirkepov Journal of Korean medical science 35 (27), 2020 | 172 | 2020 |
Plagiarism in the context of education and evolving detection strategies AY Gasparyan, B Nurmashev, B Seksenbayev, VI Trukhachev, ... Journal of Korean medical science 32 (8), 1220-1227, 2017 | 143 | 2017 |
COVID-19 and the clinical course of rheumatic manifestations S Ahmed, O Zimba, AY Gasparyan Clinical rheumatology 40, 2611-2619, 2021 | 129 | 2021 |
The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases AY Gasparyan, A Stavropoulos-Kalinoglou, DP Mikhailidis, TE Toms, ... Current Vascular Pharmacology 8 (4), 437-449, 2010 | 128 | 2010 |
Association of mean platelet volume with hypertension in rheumatoid arthritis AY Gasparyan, A Stavropoulos-Kalinoglou, TE Toms, KMJ Douglas, ... Inflammation & Allergy-Drug Targets 9 (1), 45-50, 2010 | 123 | 2010 |
Authorship problems in scholarly journals: considerations for authors, peer reviewers and editors AY Gasparyan, L Ayvazyan, GD Kitas Rheumatology International 33 (2), 277-284, 2013 | 120 | 2013 |
The pressure to publish more and the scope of predatory publishing activities AY Gasparyan, B Nurmashev, AA Voronov, AN Gerasimov, AM Koroleva, ... Journal of Korean medical science 31 (12), 1874-1878, 2016 | 116 | 2016 |
Researcher and author impact metrics: variety, value, and context AY Gasparyan, M Yessirkepov, A Duisenova, VI Trukhachev, ... Journal of Korean medical science 33 (18), 2018 | 109 | 2018 |
Researcher and author profiles: opportunities, advantages, and limitations AY Gasparyan, B Nurmashev, M Yessirkepov, DA Endovitskiy, ... Journal of Korean medical science 32 (11), 1749-1756, 2017 | 99 | 2017 |
Rewarding peer reviewers: maintaining the integrity of science communication AY Gasparyan, AN Gerasimov, AA Voronov, GD Kitas Journal of Korean medical science 30 (4), 360-364, 2015 | 92 | 2015 |
Multidisciplinary bibliographic databases AY Gasparyan, L Ayvazyan, GD Kitas Journal of Korean Medical Science 28 (9), 1270-1275, 2013 | 90 | 2013 |